Director's Dealing

RNS Number : 1425I

Venn Life Sciences Holdings PLC

27 May 2014

 



27 May 2014                                 Venn Life Sciences Holdings Plc

("Venn" or the "Company")

Director's Dealing

Venn Life Sciences (AIM: VENN), a growing Clinical Research Organisation (CRO) providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, announces that David Evans, a director, has today purchased 210,000 ordinary shares of 0.1 pence each in the Company at a price of 20.5 pence per share.

David Evans now holds 289,033 ordinary shares of 0.1 pence each, representing 1.03 per cent. of the Company's issued share capital.

Enquiries:
Venn Life Sciences Holdings Plc
Tony Richardson, Chief Executive Officer	Tel: [phone]
Zeus Capital Limited (Nominated Adviser and Broker)
Ross Andrews/Andrew Jones (Corporate Finance)	Tel: [phone]
Dominic Wilson (Institutional Sales)	Tel: [phone]
Walbrook PR Ltd Paul McManus	Tel: [phone] or [e-mail] Mob: [phone]
Lianne Cawthorne	Mob: [phone]

 

END

 

 

RDSBXGDUXDDBGSR